TrialMedical oncology (Northwood, London, England)2017

No significant impact of prior treatment profile with docetaxel on the efficacy of cabazitaxel in Japanese patients with metastatic castration-resistant prostate cancer.

Hideaki Miyake et al.PubMed ↗Publisher ↗

No numbers read from the abstract.